nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Hallucination—Betamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Gadodiamide—Hallucination—Dexamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Gadodiamide—Ataxia—Methotrexate—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Gadodiamide—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00405	0.00405	CcSEcCtD
Gadodiamide—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00404	0.00404	CcSEcCtD
Gadodiamide—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Gadodiamide—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Gadodiamide—Visual impairment—Betamethasone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Gadodiamide—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Gadodiamide—Malaise—Prednisolone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Gadodiamide—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Gadodiamide—Syncope—Prednisolone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Gadodiamide—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Gadodiamide—Convulsion—Prednisolone—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Gadodiamide—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Gadodiamide—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Gadodiamide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Gadodiamide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Gadodiamide—Discomfort—Prednisolone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Gadodiamide—Hallucination—Prednisone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Gadodiamide—Malaise—Triamcinolone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Gadodiamide—Malaise—Methylprednisolone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Gadodiamide—Syncope—Triamcinolone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Gadodiamide—Syncope—Methylprednisolone—ankylosing spondylitis	0.00353	0.00353	CcSEcCtD
Gadodiamide—Oedema—Prednisolone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Gadodiamide—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Gadodiamide—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Gadodiamide—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Gadodiamide—Shock—Prednisolone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Gadodiamide—Convulsion—Triamcinolone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Gadodiamide—Tachycardia—Prednisolone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Gadodiamide—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Gadodiamide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Gadodiamide—Myalgia—Triamcinolone—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Gadodiamide—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Gadodiamide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Gadodiamide—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Gadodiamide—Flushing—Prednisone—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Gadodiamide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Gadodiamide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Gadodiamide—Discomfort—Triamcinolone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Gadodiamide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Gadodiamide—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00329	0.00329	CcSEcCtD
Gadodiamide—Renal failure—Methotrexate—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Gadodiamide—Malaise—Betamethasone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Gadodiamide—Malaise—Dexamethasone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Gadodiamide—Oedema—Triamcinolone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Gadodiamide—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Gadodiamide—Syncope—Betamethasone—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Gadodiamide—Syncope—Dexamethasone—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Gadodiamide—Arrhythmia—Prednisone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Gadodiamide—Infection—Triamcinolone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Gadodiamide—Infection—Methylprednisolone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Gadodiamide—Shock—Triamcinolone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Gadodiamide—Shock—Methylprednisolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Gadodiamide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Gadodiamide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Gadodiamide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Gadodiamide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Gadodiamide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Gadodiamide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Gadodiamide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Gadodiamide—Convulsion—Dexamethasone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Gadodiamide—Convulsion—Betamethasone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Gadodiamide—Myalgia—Dexamethasone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Gadodiamide—Myalgia—Betamethasone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Gadodiamide—Anxiety—Betamethasone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Gadodiamide—Anxiety—Dexamethasone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Gadodiamide—Discomfort—Betamethasone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Gadodiamide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Gadodiamide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Gadodiamide—Pain—Prednisolone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Gadodiamide—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Gadodiamide—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Gadodiamide—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Gadodiamide—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Gadodiamide—Oedema—Dexamethasone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Gadodiamide—Oedema—Betamethasone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Gadodiamide—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Gadodiamide—Infection—Dexamethasone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Gadodiamide—Infection—Betamethasone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Gadodiamide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Gadodiamide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Gadodiamide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Gadodiamide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Gadodiamide—Visual impairment—Methotrexate—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Gadodiamide—Shock—Betamethasone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Gadodiamide—Shock—Dexamethasone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Gadodiamide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Gadodiamide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Gadodiamide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Gadodiamide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Gadodiamide—Tachycardia—Betamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Gadodiamide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Gadodiamide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Gadodiamide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Gadodiamide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Gadodiamide—Malaise—Prednisone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Gadodiamide—Syncope—Prednisone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Gadodiamide—Tinnitus—Methotrexate—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Gadodiamide—Urticaria—Prednisolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Gadodiamide—Fatigue—Triamcinolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Gadodiamide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Gadodiamide—Pain—Triamcinolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Gadodiamide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Gadodiamide—Hypotension—Dexamethasone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Gadodiamide—Hypotension—Betamethasone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Gadodiamide—Convulsion—Prednisone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Gadodiamide—Chills—Methotrexate—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Gadodiamide—Myalgia—Prednisone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Gadodiamide—Arthralgia—Prednisone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Gadodiamide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Gadodiamide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Gadodiamide—Anxiety—Prednisone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Gadodiamide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Gadodiamide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Gadodiamide—Discomfort—Prednisone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Gadodiamide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Gadodiamide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Gadodiamide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Gadodiamide—Urticaria—Triamcinolone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Gadodiamide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Gadodiamide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Gadodiamide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Gadodiamide—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Gadodiamide—Oedema—Prednisone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Gadodiamide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Gadodiamide—Infection—Prednisone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Gadodiamide—Fatigue—Betamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Gadodiamide—Fatigue—Dexamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Gadodiamide—Shock—Prednisone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Gadodiamide—Pain—Betamethasone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Gadodiamide—Pain—Dexamethasone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Gadodiamide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Gadodiamide—Tachycardia—Prednisone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Gadodiamide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Gadodiamide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Gadodiamide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Gadodiamide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Gadodiamide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Gadodiamide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Gadodiamide—Malaise—Methotrexate—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Gadodiamide—Urticaria—Betamethasone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Gadodiamide—Urticaria—Dexamethasone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Gadodiamide—Dizziness—Prednisolone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Gadodiamide—Asthenia—Triamcinolone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Gadodiamide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Gadodiamide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Gadodiamide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Gadodiamide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Gadodiamide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Gadodiamide—Paraesthesia—Prednisone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Gadodiamide—Pruritus—Triamcinolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Gadodiamide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Gadodiamide—Convulsion—Methotrexate—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Gadodiamide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Gadodiamide—Myalgia—Methotrexate—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Gadodiamide—Arthralgia—Methotrexate—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Gadodiamide—Chest pain—Methotrexate—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Gadodiamide—Rash—Prednisolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Gadodiamide—Dermatitis—Prednisolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Gadodiamide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Gadodiamide—Fatigue—Prednisone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Gadodiamide—Headache—Prednisolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Gadodiamide—Discomfort—Methotrexate—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Gadodiamide—Dizziness—Triamcinolone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Gadodiamide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Gadodiamide—Infection—Methotrexate—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Gadodiamide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Gadodiamide—Asthenia—Dexamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Gadodiamide—Asthenia—Betamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Gadodiamide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Gadodiamide—Nausea—Prednisolone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Gadodiamide—Pruritus—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Gadodiamide—Pruritus—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Gadodiamide—Vomiting—Triamcinolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Gadodiamide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Gadodiamide—Rash—Triamcinolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Gadodiamide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Gadodiamide—Rash—Methylprednisolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Gadodiamide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Gadodiamide—Urticaria—Prednisone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Gadodiamide—Headache—Triamcinolone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Gadodiamide—Headache—Methylprednisolone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Gadodiamide—Body temperature increased—Prednisone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Gadodiamide—Abdominal pain—Prednisone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Gadodiamide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Gadodiamide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Gadodiamide—Hypotension—Methotrexate—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Gadodiamide—Dizziness—Betamethasone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Gadodiamide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Gadodiamide—Nausea—Triamcinolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gadodiamide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gadodiamide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gadodiamide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Gadodiamide—Somnolence—Methotrexate—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Gadodiamide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Gadodiamide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Gadodiamide—Vomiting—Dexamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Gadodiamide—Vomiting—Betamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Gadodiamide—Rash—Dexamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Gadodiamide—Rash—Betamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Gadodiamide—Dermatitis—Betamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Gadodiamide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Gadodiamide—Fatigue—Methotrexate—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Gadodiamide—Headache—Betamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Gadodiamide—Headache—Dexamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Gadodiamide—Asthenia—Prednisone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Gadodiamide—Pain—Methotrexate—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Gadodiamide—Pruritus—Prednisone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Gadodiamide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Gadodiamide—Diarrhoea—Prednisone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Gadodiamide—Nausea—Betamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Gadodiamide—Nausea—Dexamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Gadodiamide—Urticaria—Methotrexate—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Gadodiamide—Dizziness—Prednisone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Gadodiamide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Gadodiamide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Gadodiamide—Vomiting—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Gadodiamide—Rash—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Gadodiamide—Dermatitis—Prednisone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Gadodiamide—Headache—Prednisone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Gadodiamide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Gadodiamide—Asthenia—Methotrexate—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Gadodiamide—Nausea—Prednisone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Gadodiamide—Pruritus—Methotrexate—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Gadodiamide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Gadodiamide—Dizziness—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Gadodiamide—Vomiting—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Gadodiamide—Rash—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Gadodiamide—Dermatitis—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Gadodiamide—Headache—Methotrexate—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Gadodiamide—Nausea—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
